New industry research, conducted by the Tufts Center for the Study of Drug Development (CSDD) in collaboration with Teckro, gathered responses from investigative site staff on how and when they interact with the clinical trial protocol.
This webinar features experts who present the current challenges with clinical trial diversity, and how we can make trials more accessible for both patients and physicians.
This solution overview illustrates how with Teckro sponsors can overcome COVID-19 disruptions for ongoing clinical trials and accelerate new infectious disease trials.